SAN DIEGO, Aug. 23, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending in New York on behalf of certain purchasers of shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) over alleged Securities Laws Violations by Albany Molecular Research.
Investors who purchased shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) prior to August 2014 and continue to hold any of those Albany NASDAQ:AMRI shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
In November 2014 a lawsuit was filed against Albany Molecular Research, Inc. over alleged securities laws violations. The plaintiff alleged that the defendants violated Federal Securities Laws by issuing certain allegedly materially false and misleading statements about its business and financial prospects. In March 2015 an amended complaint was filed by the plaintiff and in November 2015 the defendants filed their motion to dismiss the case. In July 2016 the court denied the defendants’ motions to dismiss the case.
Those who purchased shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) prior to August 2014 and continue to hold any of those NASDAQ:AMRI shares have also certain options and should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Update in Lawsuit for Investors in Albany Molecular Research, Inc. shares announced by Shareholders Foundation
| Source: Shareholders Foundation, Inc.